Weronika Krzyżanowska Selected Research

Neuroblastoma

10/2016	Participation of protein kinases in cytotoxic and proapoptotic effects of ethylene glycol ethers and their metabolites in SH-SY5Y cells.
2/2016	Protective Effects of Bacopa Monnieri on Hydrogen Peroxide and Staurosporine: Induced Damage of Human Neuroblastoma SH-SY5Y Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weronika Krzyżanowska Research Topics

Disease

3	Brain Ischemia (Cerebral Ischemia) 07/2021 - 04/2014
3	Ischemia 07/2021 - 04/2014
2	Hyperthyroidism 03/2020 - 01/2018
2	Neuroblastoma 10/2016 - 02/2016
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2021
1	Schizophrenia (Dementia Praecox) 08/2020
1	Stroke (Strokes) 01/2017

Drug/Important Bio-Agent (IBA)

2	Caspase 3 (Caspase-3)IBA 07/2021 - 10/2016
2	Glutamic Acid (Glutamate)FDA Link 01/2017 - 04/2014
2	Acetylcysteine (Siran)FDA LinkGeneric 01/2017 - 04/2014
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 07/2021
1	Interleukin-6 (Interleukin 6)IBA 07/2021
1	Nerve Growth Factors (Neurotrophins)IBA 07/2021
1	LipopolysaccharidesIBA 08/2020
1	Poly I-CIBA 08/2020
1	Progesterone FDA LinkGeneric 03/2020
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2017
1	phenoxyethanol (2-phenoxyethanol)IBA 10/2016
1	2-ethoxyethanol (Cellosolve)IBA 10/2016
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2016
1	n-butoxyethanol (2-butoxyethanol)IBA 10/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2016
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2016
1	StaurosporineIBA 02/2016
1	LactamsIBA 04/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2014
1	Amitriptyline (Elavil)FDA LinkGeneric 04/2014
1	Riluzole FDA LinkGeneric 04/2014

Therapy/Procedure

1	Topical Administration 01/2018
1	Therapeutics 01/2017